BBA
Baker Bros. Advisors’s TScan Therapeutics TCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Hold |
2,784,792
| – | – | 0.04% | 70 |
|
|
2025
Q1 | $3.84M | Hold |
2,784,792
| – | – | 0.04% | 64 |
|
|
2024
Q4 | $8.47M | Hold |
2,784,792
| – | – | 0.09% | 56 |
|
|
2024
Q3 | $13.9M | Hold |
2,784,792
| – | – | 0.14% | 47 |
|
|
2024
Q2 | $16.3M | Hold |
2,784,792
| – | – | 0.21% | 43 |
|
|
2024
Q1 | $22.1M | Hold |
2,784,792
| – | – | 0.28% | 40 |
|
|
2023
Q4 | $16.2M | Hold |
2,784,792
| – | – | 0.18% | 40 |
|
|
2023
Q3 | $7.13M | Hold |
2,784,792
| – | – | 0.04% | 57 |
|
|
2023
Q2 | $6.96M | Hold |
2,784,792
| – | – | 0.04% | 67 |
|
|
2023
Q1 | $5.85M | Hold |
2,784,792
| – | – | 0.03% | 69 |
|
|
2022
Q4 | $4.32M | Hold |
2,784,792
| – | – | 0.03% | 81 |
|
|
2022
Q3 | $8.49M | Hold |
2,784,792
| – | – | 0.06% | 65 |
|
|
2022
Q2 | $8.76M | Buy |
2,784,792
+1,359,792
| +95% | +$4.28M | 0.05% | 65 |
|
|
2022
Q1 | $3.99M | Hold |
1,425,000
| – | – | 0.02% | 92 |
|
|
2021
Q4 | $6.41M | Hold |
1,425,000
| – | – | 0.03% | 89 |
|
|
2021
Q3 | $11.9M | Buy |
+1,425,000
| New | +$11.9M | 0.05% | 74 |
|